Bibliometric Analysis of RNA Vaccines for Cancer

Overview

Journal Hum Vaccin Immunother

Specialty Allergy & Immunology

Date 2023 Jul 18

PMID 37464256

Authors

Xue Yang

Jian Kang

Zhaohui Xing

Yongtao Sun

Zhipeng Liu

Nannan Li

Jirui Niu

Affiliations

Soon will be listed here.

Abstract

Cancer represents a challenging medical problem worldwide. Several exploratory studies have been conducted to overcome these limitations. RNA vaccines play an important role in cancer prevention and treatment. Recent studies have shown that RNA vaccines play an important role in cancer prevention. However, there are currently no relevant bibliometric studies. This study aimed to apply bibliometrics to summarize the knowledge structure and research hotspots regarding the role of RNA vaccines in cancer. Publications related to RNA vaccines in cancer were searched on the web of science core collection (WoSCC) database. VOSviewers, CiteSpace and R package "bibliometrix" were used to conduct this bibliometric analysis. A total of 1399 articles were included, comprising 803 original articles and 596 reviews. The number of studies on RNA vaccines against cancer has been increasing annually. China and the United States were the principal countries of origin of publications. Johannes Gutenberg University Mainz, NCI, and Duke University were the main organizations. is the leading journal in the field. Hot keywords included tumor antigens, lipid nanoparticles, emerging roles, and dendritic cells. This is the bibliometric study to summarize the research trends and development of RNA vaccines for cancer. This information will provide a reference for researchers studying RNA vaccines against cancer.

Citing Articles

Overview of current research on traditional Chinese medicine in skin disease treatment: a bibliometric analysis from 2014 to 2024.

Li L, Zhang L, Li Y, Cai Y, Wen X, Zheng C Pharm Biol. 2025; 63(1):27-41.

PMID: 39745060 PMC: 11703412. DOI: 10.1080/13880209.2024.2443415.

Research hotspots and trends in immunotherapy for cholangiocarcinoma: a bibliometric analysis (2014-2023).

Qu X, Wang Q, Zhu F, Liang H, Long Z, Wu Y Front Immunol. 2024; 15:1436315.

PMID: 39660136 PMC: 11628549. DOI: 10.3389/fimmu.2024.1436315.

References

Lin J, Ling F, Huang P, Chen M, Song M, Lu K . The Development of GABAergic Network in Depression in Recent 17 Years: A Visual Analysis Based on CiteSpace and VOSviewer. Front Psychiatry. 2022; 13:874137. PMC: 9157549. DOI: 10.3389/fpsyt.2022.874137. View

Crocchiolo R, Gallina A, Pani A, Campisi D, Cento V, Sacchi N . Polymorphism of the HLA system and weak antibody response to BNT162b2 mRNA vaccine. HLA. 2022; 99(3):183-191. DOI: 10.1111/tan.14546. View

Zhou Q, Kong H, He B, Zhou S . Bibliometric Analysis of Bronchopulmonary Dysplasia in Extremely Premature Infants in the Web of Science Database Using CiteSpace Software. Front Pediatr. 2021; 9:705033. PMC: 8417835. DOI: 10.3389/fped.2021.705033. View

He Z, Dai L, Zuo Y, Chen Y, Wang H, Zeng H . Hotspots and frontiers in pulmonary arterial hypertension research: a bibliometric and visualization analysis from 2011 to 2020. Bioengineered. 2022; 13(6):14667-14680. PMC: 9342150. DOI: 10.1080/21655979.2022.2100064. View

Xu H, Zhao F, Wu D, Zhang Y, Bao X, Shi F . Eliciting effective tumor immunity against ovarian cancer by cancer stem cell vaccination. Biomed Pharmacother. 2023; 161:114547. DOI: 10.1016/j.biopha.2023.114547. View

Zhang S, Xia K, Chang Y, Wei Y, Xiong Y, Tang F . LRP2 and DOCK8 Are Potential Antigens for mRNA Vaccine Development in Immunologically 'Cold' KIRC Tumours. Vaccines (Basel). 2023; 11(2). PMC: 9966310. DOI: 10.3390/vaccines11020396. View

Yan F, Cowell L, Tomkies A, Day A . Therapeutic Vaccination for HPV-Mediated Cancers. Curr Otorhinolaryngol Rep. 2023; 11(1):44-61. PMC: 9890440. DOI: 10.1007/s40136-023-00443-8. View

Susol O, Hajkova B, Zelena H, Hajek R . Third dose of COVID-19 vaccine restores immune response in patients with haematological malignancies after loss of protective antibody titres. Br J Haematol. 2022; 197(3):302-305. DOI: 10.1111/bjh.18073. View

Siegel R, Miller K, Wagle N, Jemal A . Cancer statistics, 2023. CA Cancer J Clin. 2023; 73(1):17-48. DOI: 10.3322/caac.21763. View

10.

Yang W, Cao J, Cheng H, Chen L, Yu M, Chen Y . Nanoformulations targeting immune cells for cancer therapy: mRNA therapeutics. Bioact Mater. 2022; 23:438-470. PMC: 9712057. DOI: 10.1016/j.bioactmat.2022.11.014. View

11.

Miao L, Zhang Y, Huang L . mRNA vaccine for cancer immunotherapy. Mol Cancer. 2021; 20(1):41. PMC: 7905014. DOI: 10.1186/s12943-021-01335-5. View

12.

Liu X, Zhao S, Tan L, Tan Y, Wang Y, Ye Z . Frontier and hot topics in electrochemiluminescence sensing technology based on CiteSpace bibliometric analysis. Biosens Bioelectron. 2022; 201:113932. DOI: 10.1016/j.bios.2021.113932. View

13.

Sahin U, Oehm P, Derhovanessian E, Jabulowsky R, Vormehr M, Gold M . An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma. Nature. 2020; 585(7823):107-112. DOI: 10.1038/s41586-020-2537-9. View

14.

Vittori A, Cascella M, Leonardi M, Monaco F, Nocerino D, Cuomo A . VOSviewer-Based Bibliometric Network Analysis for Evaluating Research on Juvenile Primary Fibromyalgia Syndrome (JPFS). Children (Basel). 2022; 9(5). PMC: 9139718. DOI: 10.3390/children9050637. View

15.

Boczkowski D, Nair S, Snyder D, Gilboa E . Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo. J Exp Med. 1996; 184(2):465-72. PMC: 2192710. DOI: 10.1084/jem.184.2.465. View

16.

Yang D, Wu Y, Turan I, Keil J, Li K, Chen M . Targeting intracellular Neu1 for coronavirus infection treatment. iScience. 2023; 26(2):106037. PMC: 9870608. DOI: 10.1016/j.isci.2023.106037. View

17.

Sun H, Bai W, Li X, Huang H, Cui X, Cheung T . Schizophrenia and Inflammation Research: A Bibliometric Analysis. Front Immunol. 2022; 13:907851. PMC: 9219580. DOI: 10.3389/fimmu.2022.907851. View

18.

Yang W, Mixich L, Boonstra E, Cabral H . Polymer-Based mRNA Delivery Strategies for Advanced Therapies. Adv Healthc Mater. 2023; 12(15):e2202688. PMC: 11469255. DOI: 10.1002/adhm.202202688. View

19.

Su E, Fischer S, R Demmer-Steingruber , Nigg S, Gusewell S, Albrich W . Humoral and cellular responses to mRNA-based COVID-19 booster vaccinations in patients with solid neoplasms under active treatment. ESMO Open. 2022; 7(5):100587. PMC: 9399124. DOI: 10.1016/j.esmoop.2022.100587. View

20.

Barbosa M, Galembeck E . Mapping research on biochemistry education: A bibliometric analysis. Biochem Mol Biol Educ. 2022; 50(2):201-215. DOI: 10.1002/bmb.21607. View